Data from EMA (European Medicines Agency) - Curated by EPG Health - Last updated 05 September 2018
Decrease of elevated intraocular pressure in adult patients with ocular hypertension or open-angle glaucoma.
Decrease of elevated intraocular pressure in paediatric patients aged 2 months to < 18 years with ocular hypertension or paediatric glaucoma.
An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.
The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.
View disease awareness information, treatment options and European Cystic Fibrosis Society best practice guidelines.
The Migraine Knowledge Centre features latest research on the prevalence and impact of migraine, the proposed neurological basis of the condition (and how this is being translated into new and exciting drug therapies), as well as current patient care strategies collated from headache organisations worldwide.
Double-Masked Trial of NOVA22007 (1mg/mL Ciclosporin/Cyclosporine) Versus Vehicle in Pediatric Patients With Active Severe Vernal Keratoconjunctivitis
The objective of this study is to compare the efficacy of two different dosing regimen of NOVA22007 (1mg/ml ciclosporin/cyclosporine) eye drops, emulsion versus placebo (vehicle of the formulation)...
Added 8 months ago
The aim of the present study is to evaluate the safety and efficacy of propranolol eye drops in preterm newborns...
Added 6 years ago
The aim of the study is to assess the quality of life of children who have been cured of retinoblastoma...
Added 8 years ago
Retinoblastoma is a cancer of the eye that occurs exclusively in children. The treatment for retinoblastoma may include surgery, chemotherapy,...
Added 8 years ago
Phase III Study of Multimodality Therapy Comprising Induction Chemotherapy, High-Dose Consolidation Chemotherapy, Autologous Stem Cell Transplantation, and/or Radiotherapy in Children With Extraocular Retinoblastoma
- To estimate the proportion of children with extraocular retinoblastoma who achieve long-term event-free survival after treatment with aggressive multimodality...
Added 12 years ago
This article was created from a comprehensive literature search with information taken from meta-analyses, systematic reviews, and clinical trials of children and adults.
Added 7 months ago
Lysosomal storage disorders represent a group of at least 41 genetically distinct, biochemically related, inherited diseases.
Added 1 year ago
Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of "Real-world" Evidence.
Objective: To quantitatively synthesize what is known about the benefits and harms of omalizumab in the real-world clinical management of CIU regarding urticaria activity, treatment response, and adverse events.
Added 10 hours ago
Background: Data on the prevalence and disease management of chronic urticaria (CU) and chronic spontaneous urticaria (CSU) in the pediatric population are scarce. This study assessed the prevalence of CU and CSU...
Added 12 hours ago
Severe atopic dermatitis, which affects both adults and children, is a debilitating disorder with a significant decline of patients' quality of life. Although aetiopathogenic factors are currently a topic of study and interpretation...
Added 7 days ago
This guideline covers diagnosing and managing glaucoma in people aged 18 and over. It includes recommendations on testing and referral (case-finding) for chronic open angle glaucoma and ocular hypertension, and on effective diagnosis...
Added 9 years ago
This guideline is designed for ophthalmologists managing children with strabismus (syn.squint), which is defined as a pathological misalignment of the visual axes.
Added 7 years ago
|Agency product number||EMEA/H/C/000390|
|Date First Approved||27-11-2001|
|Type||Medicinal product subject to medical prescription|
|Marketing authorisation holder||Novartis Europharm Limited|